The Philippines Has a Silent Diabetes Epidemic. Half of Those Who Have It Don't Know.

What the Numbers Actually Show

The IDF Diabetes Atlas 11th edition, published in 2025 with 2024 data, places the Western Pacific region at a 12.4 percent age-standardized diabetes prevalence among adults aged 20 to 79, the third highest of all IDF regions. The region accounts for more than a third of all adults globally living with diabetes, out of a global total of 589 million. By 2050, the Western Pacific regional total is projected to climb to 254 million, an 18 percent increase driven largely by population growth, aging, and persistent lifestyle risk factors including physical inactivity, processed food consumption, and obesity.

The undiagnosed fraction is the most alarming dimension of this picture. Globally, 42.8 percent of people with diabetes are undiagnosed. In the Western Pacific region, that proportion rises to 50 percent, the second-highest rate of undiagnosed diabetes of any IDF region in the world. Research published in The Lancet Western Pacific in November 2025 described the problem plainly: delayed diagnosis can lead directly to cardiovascular disease, kidney damage, and lower limb amputations. For the Philippines specifically, the Department of Health recorded over 656,000 confirmed cases as of 2025, but clinical and epidemiological consensus holds that actual prevalence is substantially higher when undiagnosed cases are included.

Why Type 2 Diabetes Goes Undetected for So Long

The silence of early type 2 diabetes is not incidental. It is a direct consequence of how the disease develops. In the early stages, the pancreas compensates for rising insulin resistance by producing more insulin than normal, which is enough to keep blood glucose near-normal and symptoms absent. Over months and years, this compensation gradually fails, and blood sugar rises past the thresholds associated with tissue damage, but often without producing symptoms that a person would recognize as serious. Fatigue, increased thirst, and more frequent urination are common early indicators, but each of these is easily attributed to heat, busy schedules, or simply getting older.

In the Philippines, this natural disease trajectory is compounded by structural gaps in screening access. The 2025 Lancet Western Pacific analysis identified the often-asymptomatic nature of the disease alongside limited availability of screening programs and lower uptake of health services as the primary reasons that diagnosis rates remain so low in the region. Among working-age adults, diabetes stigma adds a further barrier: the perception that a diabetes diagnosis reflects personal failure in diet or lifestyle can delay health-seeking behavior, particularly for men. Approximately 70 percent of people with diabetes globally are of working age, and the stigma burden is highest in this group.

A 2025 study published in Frontiers in Endocrinology, using data from the Global Burden of Diseases Study 2021, found that the age-standardized incidence rate of early-onset type 2 diabetes among people aged 15 to 39 in the Western Pacific region accelerated significantly in recent years, with the annual percentage change rising from 1.71 percent between 1999 and 2017 to 5.01 percent between 2017 and 2021. The COVID-19 pandemic appeared to accelerate this trend further, with observed rates exceeding historical predictions in 2020 and 2021. This is not a disease of old age anymore. It is arriving earlier, and it is arriving quietly.

What Undetected Diabetes Does to the Body Over Time

The danger of undiagnosed diabetes is not simply that treatment is delayed. It is that damage is accumulating throughout the delay. Persistently elevated blood glucose causes glycation of proteins and damage to the walls of blood vessels throughout the body. The microvascular consequences affect the kidneys, eyes, and peripheral nerves first. The macrovascular consequences, which develop over a longer timeframe, affect the heart and major arteries, contributing to coronary artery disease, stroke, and peripheral vascular disease. Both categories of damage begin before a person has any symptoms they would associate with a metabolic condition.

Diabetic nephropathy, the kidney damage caused by chronic high blood sugar, is now the leading cause of chronic kidney disease and end-stage renal disease in the Philippines. Ischaemic heart disease already topped the causes of death in the Philippines from January to July 2023, with more than 65,000 deaths recorded in just six months. Unmanaged diabetes is one of the most significant modifiable contributors to this toll. When the disease is caught late, patients often present not at a primary care clinic but at a hospital emergency department with complications that have already become irreversible.

Who Is Most at Risk in the Philippines

The established risk factors for type 2 diabetes are well documented and apply directly to the Filipino population: family history, excess body weight and abdominal obesity, physical inactivity, high intake of refined carbohydrates and ultra-processed foods, hypertension, and a history of gestational diabetes. A 2023 estimate placed approximately 27 million Filipinos in the overweight or obese category, a critical upstream driver of insulin resistance. The IDF notes that 1 in 5 live births in the Western Pacific region are affected by hyperglycaemia in pregnancy, which raises the risk of both the mother and child developing type 2 diabetes later in life.

Age is a consistent risk amplifier, but the early-onset trend documented in recent research means that screening cannot be deferred until midlife. Adults over 40 with any one of the above risk factors, and adults over 35 with two or more, meet the threshold most clinical guidelines use to recommend proactive testing. A fasting blood glucose test or HbA1c, neither of which requires specialist referral at most health centers in the Philippines, is sufficient to identify both pre-diabetes and undiagnosed type 2 diabetes before complications develop.

• A first-degree relative with diabetes substantially raises individual risk, particularly among Filipino adults with a family history on both sides
• Abdominal obesity, defined as waist circumference above 80 centimeters for women and 90 centimeters for men in Asian populations, is a more sensitive indicator of metabolic risk than general body mass index
• BPO and night-shift workers face compounded risk through disrupted circadian rhythms, which independently impair insulin secretion and glucose regulation
• People with pre-diabetes, estimated at one in three adults in comparable populations, can prevent or delay progression through weight loss of 5 to 7 percent of body weight combined with regular physical activity

What PhilHealth Covers and What the Response Looks Like

PhilHealth covers diabetes-related outpatient care through its Outpatient Disease Management Program, or OPDMP, for members diagnosed with type 2 diabetes, hypertension, or both. The program covers consultations, laboratory tests including HbA1c and fasting blood glucose, and select medications at accredited health facilities. For members who develop complications requiring hospitalization, PhilHealth's inpatient benefit packages apply to diabetic emergencies including diabetic ketoacidosis and hyperosmolar hyperglycemic state, as well as to related complications such as diabetic foot ulcer requiring debridement or amputation. Coverage specifics are updated by circular; members are advised to verify current rates with their accredited facility.

At the national level, the DOH has integrated diabetes into its Integrated Non-Communicable Disease Prevention and Control Program, which targets risk factor reduction through community-based health promotion, expanded access to HbA1c testing at primary health care facilities, and inclusion of diabetes screening in annual health checks for government workers. The challenge, as documented by both the IDF and the Lancet Western Pacific analysis, is translating policy into consistent screening uptake, particularly among working-age adults who remain outside formal healthcare contact for years at a time.